{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["dca42b48-ebd6-41c5-8233-bcdf01cb0d4e", "Q3", 7758, "CALIFORNIA LIFE SCIENCES", 110904, "CALIFORNIA LIFE SCIENCES", 2012, "third_quarter", "2012-10-08T19:56:20.350000-04:00", 160000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/dca42b48-ebd6-41c5-8233-bcdf01cb0d4e/\", \"filing_uuid\": \"dca42b48-ebd6-41c5-8233-bcdf01cb0d4e\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2012, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/dca42b48-ebd6-41c5-8233-bcdf01cb0d4e/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"160000.00\", \"expenses_method\": \"a\", \"expenses_method_display\": \"Method A - Reporting amounts using LDA definitions only\", \"posted_by_name\": \"Holly Frisque, Sr. Director of Operations\", \"dt_posted\": \"2012-10-08T19:56:20.350000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"888 PROSPECT STREET, #220\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"LA JOLLA\", \"registrant_state\": \"CA\", \"registrant_zip\": \"92037\", \"registrant\": {\"id\": 7758, \"url\": \"https://lda.senate.gov/api/v1/registrants/7758/\", \"house_registrant_id\": 33793, \"name\": \"CALIFORNIA LIFE SCIENCES\", \"description\": null, \"address_1\": \"4242 Campus Point Court\", \"address_2\": \"Suite 110\", \"address_3\": null, \"address_4\": null, \"city\": \"San Diego\", \"state\": \"CA\", \"state_display\": \"California\", \"zip\": \"92121\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"JAYNE MCNICOL\", \"contact_telephone\": \"+1 650-871-3270\", \"dt_updated\": \"2026-01-19T17:24:30.729442-05:00\"}, \"client\": {\"id\": 110904, \"url\": \"https://lda.senate.gov/api/v1/clients/110904/\", \"client_id\": 12, \"name\": \"CALIFORNIA LIFE SCIENCES\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"CA\", \"ppb_state_display\": \"California\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"1996-02-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"Support repeal of medical device tax. Support extension of R&D tax credit.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 39820, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"TODD\", \"nickname\": null, \"middle_name\": \"E\", \"last_name\": \"GILLENWATER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB).\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 39820, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"TODD\", \"nickname\": null, \"middle_name\": \"E\", \"last_name\": \"GILLENWATER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Address concerns with Medicare Independent Payment Advisory Board (IPAB).\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 39820, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"TODD\", \"nickname\": null, \"middle_name\": \"E\", \"last_name\": \"GILLENWATER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations. Support protection of US law regarding biosimilars (12 years data exclusivity).\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 39820, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"TODD\", \"nickname\": null, \"middle_name\": \"E\", \"last_name\": \"GILLENWATER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["dca42b48-ebd6-41c5-8233-bcdf01cb0d4e"], "units": {}, "query_ms": 1.167929032817483, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}